There’s a growing trend of LMS platforms leveraging AI to offer smart suggestions, automated assessments and adaptive ...

In today’s digital age, misinformation spreads faster than ever, often driven by sensational headlines and influencer content ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab) has shown continued benefit over four years, according ...

Novo Nordisk’s Alhemo (concizumab-mtci) has been approved by the US Food and Drug Administration (FDA) to prevent or reduce ...

Yet this simple difference translated into a median progression-free survival (PFS) of 11.3 months versus 5.7 months for ...

Eli Lilly’s GIP/GLP-1 dual receptor agonist Mounjaro (tirzepatide) has demonstrated cardiovascular protection in a late-stage ...

The most widely used measure of health-related self-efficacy is the Patient Activation Measure (PAM). It is a ...

The new initiative, FDA PreCheck, was developed in response to President Donald Trump’s executive order to accelerate the ...

It is hoped the new formulation will offer patients greater freedom and flexibility compared to the liquid version ...

AstraZeneca (AZ) has announced that Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) has been recommended by ...

MSD – known as Merck & Co in the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has been ...

Patient engagement is one of the most reliable ways to drive long-term health outcomes and a critical benchmark for ...